Reuters
Published Feb 20, 2021 11:32PM ET
KUALA LUMPUR (Reuters) - Malaysia moved up its COVID-19 inoculation drive by two days as the first batch of vaccines arrived in the Southeast Asian nation on Sunday.
Malaysia aims to vaccinate at least 80% of its 32 million people within a year as it pushes to revive an economy that, slammed by coronavirus-related curbs, recorded its worst slump in over two decades in 2020.
It has imposed more lockdowns this year amid a fresh wave of coronavirus infections. The country has recorded 280,272 cases and 1,051 deaths.
A total of 312,390 doses of the Pfizer-BioNTech vaccine were delivered to Malaysia on Sunday morning, with more expected in coming weeks.
"The second delivery will be made on Feb. 26, and we will continue to receive ( Pfizer (NYSE:PFE)) deliveries every two weeks until it is completed," Science Minister Khairy Jamaluddin said in a virtual news conference.
Malaysia has secured 32 million doses from Pfizer and BioNTech.
Vaccine doses from China's Sinovac Biotech are scheduled to be delivered in bulk on Feb. 27, pending approval from local regulators, Khairy said.
The national vaccine rollout will begin Wednesday, earlier than initially scheduled, with Prime Minister Muhyiddin Yassin and Health Ministry Director General Noor Hisham Abdullah set to receive the first doses, Khairy said.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.